This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Evaluating Efficacy and Safety of Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Chemotherapy

Expanded access is temporarily not available for this treatment.
Sponsor:
Collaborators:
Guangdong General Hospital
Shanghai Pulmonary Hospital, Shanghai, China
Information provided by:
Shanghai Chest Hospital
ClinicalTrials.gov Identifier:
NCT01297101
First received: February 15, 2011
Last updated: NA
Last verified: January 2011
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: Expanded access is temporarily not available for this treatment.
  Study Completion Date: No date given
  Primary Completion Date: No date given